Hengrui Pharma: SHR-2173 injection was approved for clinical trial. Hengrui Pharma announced that its subsidiary, Guangdong Hengrui Pharma Co., Ltd., received the Notice of Approval for Clinical Trial of SHR-2173 injection approved and issued by National Medical Products Administration, and agreed to carry out clinical trial. The indication is lupus nephritis. SHR-2173 injection is a therapeutic biological product independently developed by the company, and the research and development expenses have been invested about 45.03 million yuan. The period from research and development to listing of drugs is long, there are many links, and there are uncertain factors. The company will actively promote research and development projects and fulfill its information disclosure obligations.Astana Airlines resumed the route from Urumqi to Astana. On December 13th, according to Astana Airlines, Astana Airlines resumed the Urumqi-Astana flight from December 1st, with 2 flights per week. The resumed KC flight KC287 departs from Astana (NQZ) at 19: 30 every Tuesday and Saturday and arrives in Urumqi (URC) at 1: 00 the next day; KC288 departs from Urumchi (URC) at 2 o'clock every Wednesday and Sunday and arrives in Astana (NQZ) at 1: 45, all of which are local time. In addition, Astana Airlines also operates regular flights from Urumqi to Almaty, four times a week.Deutsche Bank: There is little hope that the British economy will rebound at the end of the year. Sanjay Raja, an economist at Deutsche Bank, wrote in a research report that the British economy will face more twists and turns in the future. Data released on Friday showed that Britain's GDP contracted again in October from the previous month, which surprised the market. Raja said that business surveys predict that economic activity will further weaken in the last few months of this year. In his research report, he reminded investors that the uncertainty in taxation and expenditure, coupled with the reduction in retail and service consumption caused by bad weather, added more resistance to Britain's fragile economic recovery.
Puli Pharmaceutical Co., Ltd.: It won the bid for the tenth batch of national centralized drug procurement. According to Puli Pharmaceutical, on December 12, Puli Pharmaceutical's meglumine gadolinium tetate injection (trade name: Puli Yingxian) and Posaconazole injection (trade name: Puli Posa) both won the bid for the tenth batch of national centralized drug procurement.Zaks, managing director of the European Central Bank: If necessary, the interest rate can be greatly reduced. zaks, managing director of the European Central Bank, said that if economic development requires it, the interest rate cut may be increased. Although zaks thinks that the gradual approach is appropriate, he warns that the impact of geopolitics and war may bring "new impetus" to inflation. Kazakhstan said in a blog post on Friday: "If necessary, this range can be greater than 0.25%." "The current method-analysis/decision based on data and each meeting-is very suitable for this situation." Zaks also said that the future trend of interest rates is also very clear, that is, downward. The neutral interest rate is closer to 2% than 3%, so it is still necessary to cut interest rates sharply.On the 13th, caustic soda dropped by 3.03%, and the latest main contract positions changed as follows. According to the exchange data, as of December 13th, the main contract caustic soda 2501 closed, with a turnover of 57,100 lots. The position data showed that the top 20 seats were clear, and the difference position was 1,383 lots. The total contract turnover of caustic soda futures was 94,800 lots, an increase of 27,900 lots over the previous day. The first 20 seats in the contract held 71,100 lots, an increase of 2,202 lots over the previous day. Short positions in the top 20 seats of the contract were 72,700 lots, an increase of 1,157 lots over the previous day. (Sina Futures)
The main contract of Shanghai and Shenzhen 300 stock index futures (IF) fell by 2.00% in the day and is now reported at 3,955.2 points.Shanghai Electric established a new company including machinery and equipment sales business. According to the enterprise search APP, Shanghai Dixi New Energy Co., Ltd. was established with Ye Can as its legal representative and registered capital of 1 million yuan. Its business scope includes: power generation business, power transmission business and power supply (distribution) business; Installation, maintenance and testing of power transmission, power supply and power reception facilities; Mechanical equipment sales; Mechanical and electrical equipment sales, etc. Enterprise survey shows that the company is wholly owned by Shanghai Electric New Energy Development Co., Ltd., a subsidiary of Shanghai Electric.On the 13th, silver fell by 1.91%, and the latest main contract positions changed as follows. According to the exchange data, as of December 13th, the main contract silver was 2,502, up or down by -1.91%, with a turnover of 1,004,900 lots. The position data showed that the top 20 seats were net, and the difference position was 30,444 lots. The total turnover of silver futures contracts was 1,505,900 lots, an increase of 417,500 lots over the previous day. The first 20 seats in the contract held 335,600 lots, a decrease of 15,200 lots from the previous day. The short positions in the top 20 seats of the contract were 251,300 lots, an increase of 17,500 lots over the previous day. (Sina Futures)
Strategy guide
12-14
Strategy guide
12-14
Strategy guide
12-14